|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | |||||||||||||
| Current Assets | |||||||||||||
| Cash | |||||||||||||
| Prepaid income tax | |||||||||||||
| Prepaid expenses | |||||||||||||
| Deferred income tax asset | |||||||||||||
| Investments held in Trust Account | |||||||||||||
| Total Current Assets | |||||||||||||
| Noncurrent Assets | |||||||||||||
| Deferred income tax asset | |||||||||||||
| Investments held in Trust Account | |||||||||||||
| Total Noncurrent Assets | |||||||||||||
| Total Assets | |||||||||||||
| Current Liabilities | |||||||||||||
| Other payable – related party | |||||||||||||
| Other payable – Huture | |||||||||||||
| Accounts payable and accrued expenses | |||||||||||||
| Franchise tax payable | |||||||||||||
| Income tax payable | |||||||||||||
| Excise tax payable | |||||||||||||
| Promissory note – related party | |||||||||||||
| Deferred underwriting fee payable | |||||||||||||
| Redeemed common stock payable to public stockholders | |||||||||||||
| Promissory note | |||||||||||||
| Huture | |||||||||||||
| Bestpath | |||||||||||||
| Total promissory note | |||||||||||||
| Promissory note – Huture | |||||||||||||
| Promissory note – Bestpath | |||||||||||||
| Total Current Liabilities | |||||||||||||
| Deferred underwriting fee payable | |||||||||||||
| Total Liabilities | |||||||||||||
| Common stock subject to possible redemption, $0.0001 par value; 10,000,000 shares authorized; 107,987 shares and 805,352 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | |||||||||||||
| Stockholders’ Deficit | |||||||||||||
| Common stock, $0.0001 par value; 10,000,000 shares authorized; 1,623,060 shares issued and outstanding (excluding 107,987 shares and 805,352 shares subject to possible redemption at September 30, 2025 and December 31, 2024, respectively) | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total Stockholders’ Deficit | |||||||||||||
| Total Liabilities, Redeemable Common Stock and Stockholders’ Deficit | |||||||||||||
Loading...
